The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

spending hurt life science tools maker Thermo Fisher Scientific. From a stock perspective, an underweight position in Tesla and lack of exposure to Broadcom drove the majority of relative ...

ClearBridge Large Cap Growth Strategy highlighted stocks like ICON Public Limited Company ... spending negatively impacting portfolio holding Thermo Fisher Scientific. Despite weak recent ...

Leading companies, such as Cambrex, Cook Medical, ICON, and Labcorp, put this region on the map ... growth with relocation and expansion announcements, with ProKidney and Thermo Fisher Scientific ...

In a report released on February 4, Conor McNamara from RBC Capital maintained a Buy rating on OmniAb (OABI – Research Report), with a price ...

(RTTNews) - Thermo Fisher Scientific (TMO) Tuesday announced that it has entered a 10-year virtual power purchasing agreement with international renewable energy developer X-ELIO. This collaboration ...

Earlier this week, Franco-German peer Sartorius reported preliminary annual results that beat expectations and posted a 23.1% ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 2.22% to $580.57 Tuesday, on what proved to be an all-around great ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Shares of Thermo Fisher Scientific jumped Thursday after the company's fourth-quarter results topped estimates, as sales increased across all four of its divisions.